Ningbo David Medical Device Co., Ltd. (SHE:300314)
China · Delayed Price · Currency is CNY 14.19
+0.23 (1.65%)
Mar 10, 2026, 10:45 AM CST
SHE:300314 Market Cap
SHE:300314 has a market cap or net worth of 4.02 billion as of March 9, 2026. Its market cap has increased by 21.08% in one year.
Market Cap
4.02B
Enterprise Value
3.43B
Revenue
516.76M
Ranking
n/a
PE Ratio
60.04
Stock Price
14.19
Market Cap Chart
Since May 8, 2012, SHE:300314's market cap has increased from 2.39B to 4.02B, an increase of 68.08%. That is a compound annual growth rate of 3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.02B | 10.97% |
| Dec 31, 2025 | 3.62B | 11.72% |
| Dec 31, 2024 | 3.24B | -25.63% |
| Dec 29, 2023 | 4.36B | 16.64% |
| Dec 30, 2022 | 3.74B | -4.56% |
| Dec 31, 2021 | 3.92B | -17.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou AGS MedTech | 4.69B |
| Medprin Regenerative Medical Technologies | 4.60B |
| Shanghai Kinetic Medical | 4.43B |
| Zhejiang Orient Gene Biotech | 4.43B |
| Nanjing Medlander Medical Technology | 4.33B |
| Getein Biotech | 4.25B |
| Wuhan Easy Diagnosis Biomedicine | 4.06B |
| Beijing Leadman Biochemistry | 3.74B |